GLP-2 increased bsAUC for plasma glucagon during euglycemia (−41 ± 166 [placebo] vs 306 ± 197 pmol/L × min [GLP-2]; P < .005), but did not significantly affect bsAUC for plasma glucagon during hypoglycemia (1243 ± 533 [placebo] vs 1406 ± 350 pmol/L × min [GLP-2]), or hyperglycemia (−488 ± 196 [placebo] vs −485 ± 286 pmol/L × min [GLP-2]) (Fig. 2D-2F, Table 3). Here, GCG is linked to Hypoglycemia.